市场调查报告书
商品编码
1256372
体脂测量市场——按产品(生物阻抗分析仪、卡尺、静水压称重、空气置换体积描记术、DEXA)按最终用途(医院、诊所、健身中心)分类,全球预测,2023-2032 年Body Fat Measurement Market - By Product (Bioimpedance Analyzers, Calipers, Hydrostatic Weighing, Air-Displacement Plethysmography, Dual-energy X-ray absorptiometry (DEXA)), By End-use (Hospitals, Clinics, Fitness Centers) & Global Forecast, 2023 - 2032 |
体脂测量市场预计将从 2023 年到 2032 年显着增长,因为能够在临床环境中测量多个身体参数的体脂测量设备不断创新。.
此外,几家主要公司积极参与先进 BIA 设备的开发也将对行业前景产生积极影响。
此外,射频、超声波、冷冻溶脂和激光等多种非侵入性治疗现在可用于治疗常见的问题部位,无需开刀手术。以支持体脂测量市场的增长潜力.
总体而言,体脂测量市场按产品、最终用途和区域进行细分。
基于产品,DEXA(双能 X 射线吸收测定)细分市场预计在 2023 年至 2032 年期间的复合年增长率将超过 8%。 DEXA 为骨骼和组织成分提供准确的身体成分扫描,包括骨矿物质密度 (BMD)、脂肪和瘦体重。 它还有助于测量全身脂肪、瘦组织、内臟脂肪和骨密度。 单次测量可提供高度准确的结果,并重现脂肪在全身的正确分布。
DEXA 扫描的高可靠性、安全性和低患者负担等优势将在未来几年促进该细分市场的增长。
考虑到最终用途,到 2032 年,诊所部分的价值预计将超过 4 亿美元。 肥胖相关疾病的增加和就诊机会的增加,尤其是在新兴国家,预计将在未来几年推动该行业的增长。 身体质量指数(BMI)方法的引入,提高了体脂测量的准确性,正在取得进展,并且来诊所的患者数量也在增加。
在区域方面,由于该地区越来越多地采用技术创新设备,预计欧洲体脂测量行业将在 2023 年至 2032 年显着增长。 不言而喻,由于久坐不动的生活方式导致的肥胖率上升以及欧洲国家迅速推出的国家肥胖管理服务也将在未来几年推动体脂测量业务的增长。 根据美国国立卫生研究院的数据,53.5% 的德国人口超重,肥胖患病率上升到成年人口的 19%。
此外,该地区人民意识的增强和先进技术的不断引进将推动该地区未来的市场增长。
Body Fat Measurement Market is projected to grow notably during 2023-2032 due to constant technological innovations in body fat measurement devices that can measure several body parameters in clinical settings. In addition, active focus of several key players in the development of advanced BIA devices will positively favor the industry outlook.
Moreover, the availability of various non-invasive treatments such as radio frequency, ultrasound, cryolipolysis, and lasers that focus on common trouble spots without the need for knife procedures would support the body fat measurement market growth potential.
Overall, the body fat measurement market is categorized in terms of product, end-use, and region.
Based on the product, the Dual Energy X-Ray Absorptiometry (DEXA) segment is anticipated to depict over 8% CAGR during 2023-2032. DEXA offers accurate body composition scans on bone and tissue composition, such as bone mineral density (BMD), fat, and lean tissue mass. The scan also helps measure whole-body fat, lean tissue, visceral fat, and bone density. It delivers results with high precision in a single measurement and replicates the proper distribution of fat throughout the body.
DEXA scan benefits such as high reliability, safety, and lesser burden on the patients will augment segmental growth in the coming years.
Considering the end-use, the clinics segment is expected to be valued at over USD 400 million by 2032. Increasing cases of obesity-related diseases and improving access to clinics especially in emerging economies, will favor segment growth over the ensuing years. The rising deployment of the body mass index (BMI) technique with more accurate technology for measuring body fat has increased the influx of patient count in clinics.
Regionally, the Europe body fat measurement industry will grow considerably during 2023-2032 owing to the increasing adoption of technologically innovative devices across the region. Not to mention, the growing cases of obesity owing to a sedentary lifestyle and the surging deployment of national obesity management services in European countries will assist the body fat measurement business growth over the coming years. As per NIH, 53.5% of the German population is overweight, with the prevalence of obesity being 19% in the adult population.
In addition, increasing awareness and constant adoption of advanced technologies across the region will push the regional market growth in the coming future.